Barclay Buck A. Phillips

Overview

Barclay Buck A. Phillips received an average of $2M in total compensation, including $185K in salary, at G1 Therapeutics from 2017 to 2019.

Source: SEC filings on April 24, 2020, April 30, 2019, and April 18, 2018.

Related executives

We found nine more executives who work or worked at G1 Therapeutics.

John Bailey

G1 Therapeutics

Chief Executive Officer

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

Mark Avagliano

G1 Therapeutics

Chief Business Officer

Mark Velleca

G1 Therapeutics

Chief Executive Officer

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

John Demaree

G1 Therapeutics

Chief Commercial Officer

James Hanson

G1 Therapeutics

General Counsel

News

You may also like